FRONTAGE
015211.1600.87% ( +0.010 )
FRONTAGE (01521)
Frontage Holdings Corporation provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical,...
- Open
- 1.150
- High
- 1.160
- Low
- 1.130
- Prev. Close
- 1.150
- Volume
- 548.00K
- Turnover
- 632.60K
- Avg Price
- 1.154
- Bid/Ask Ratio
- -40.88%
- Amplitude
- 2.61%
- 52wk High
- 1.760
- Volume Ratio
- 1.99
- Turnover Ratio
- 0.03%
FRONTAGE Analyst Rating
View MoreForecast & Rating
May 28, 2026Price forecast
HK$0.97-16.25%
Forecast & Rating
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold0.00%
- Sell50.00%
- Strong sell50.00%
News
- PUBT · Jun 29 at 11:00 AM
Frontage Labs names Chandra Prakash senior adviser, clinical services
- PR Newswire · Jun 29 at 11:00 AM
Frontage Laboratories Is Pleased to Welcome Dr. Chandra Prakash, Ph.D., as Senior Advisor, Clinical Services
- Tip Ranks · Jun 2 at 07:47 AM
Frontage Holdings Wins Strong Shareholder Backing for All AGM Resolutions
- AASTOCKS · Mar 30 at 09:02 AM
FRONTAGE Holdings' annual net profit is USD 6.79 million, an increase of 7.59 times, with no dividend declared
- Tip Ranks · Nov 20, 2025 at 03:10 AM
Frontage Holdings Delays Circular Dispatch for Major Transaction
- Zhitong · Oct 28, 2025 at 04:13 AM
FRONTAGE's revenue for the first three quarters is approximately USD 191.4 million, an increase of 0.2% year-on-year
